1. Home
  2. MBWM vs WVE Comparison

MBWM vs WVE Comparison

Compare MBWM & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBWM
  • WVE
  • Stock Information
  • Founded
  • MBWM 1997
  • WVE 2012
  • Country
  • MBWM United States
  • WVE Singapore
  • Employees
  • MBWM N/A
  • WVE N/A
  • Industry
  • MBWM Major Banks
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBWM Finance
  • WVE Health Care
  • Exchange
  • MBWM Nasdaq
  • WVE Nasdaq
  • Market Cap
  • MBWM 763.4M
  • WVE 915.6M
  • IPO Year
  • MBWM 1997
  • WVE 2015
  • Fundamental
  • Price
  • MBWM $49.25
  • WVE $9.60
  • Analyst Decision
  • MBWM Buy
  • WVE Strong Buy
  • Analyst Count
  • MBWM 4
  • WVE 16
  • Target Price
  • MBWM $53.63
  • WVE $20.00
  • AVG Volume (30 Days)
  • MBWM 55.6K
  • WVE 1.6M
  • Earning Date
  • MBWM 10-14-2025
  • WVE 07-30-2025
  • Dividend Yield
  • MBWM 3.00%
  • WVE N/A
  • EPS Growth
  • MBWM N/A
  • WVE N/A
  • EPS
  • MBWM 5.03
  • WVE N/A
  • Revenue
  • MBWM $228,384,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • MBWM $10.34
  • WVE N/A
  • Revenue Next Year
  • MBWM $11.93
  • WVE $10.02
  • P/E Ratio
  • MBWM $9.79
  • WVE N/A
  • Revenue Growth
  • MBWM 3.70
  • WVE N/A
  • 52 Week Low
  • MBWM $37.76
  • WVE $5.04
  • 52 Week High
  • MBWM $52.98
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • MBWM 60.30
  • WVE 58.88
  • Support Level
  • MBWM $47.37
  • WVE $9.26
  • Resistance Level
  • MBWM $50.23
  • WVE $10.45
  • Average True Range (ATR)
  • MBWM 1.26
  • WVE 0.52
  • MACD
  • MBWM 0.36
  • WVE 0.00
  • Stochastic Oscillator
  • MBWM 81.65
  • WVE 59.34

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: